A significant advance in cancer study is arising with the use of nanobodies to re-engage damaged p53. This vital malignant inhibitor protein is frequently inactivated in several forms of tumors, causing uncontrolled https://socialstrategie.com/story7737992/nanobodies-revive-tumor-suppressor-p53-new-potential-pathway-for-cancer-treatment